Samples
Manage and track biological samples across studies
Total Samples
1034
Cell Types
30
Conditions
29
Studies
47
Filters
Sample Data
Showing 50 of 1034 samples| NAME | SUBJECT ID | CELL TYPE | CONDITION | ASSAYS | COLLECTION DATE | ACTIONS | |
|---|---|---|---|---|---|---|---|
|
KF005-HTC5
|
3001
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF005-HTC6
|
1059
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF006-HTC1
|
407
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF006-HTC2
|
1156
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF006-HTC3
|
3338
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF006-HTC4
|
3385
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF006-HTC5
|
3001
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF006-HTC6
|
1059
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF007-HTC1
|
3159
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF007-HTC2
|
3159
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF007-HTC3
|
2058
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF007-HTC4
|
3377
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF007-HTC5
|
3851
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF008-HTC1
|
3159
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF008-HTC2
|
3159
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF008-HTC3
|
2058
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF008-HTC4
|
3377
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF008-HTC5
|
3851
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF009-HTC1
|
3159
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF009-HTC2
|
3159
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF009-HTC3
|
2058
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF009-HTC4
|
3377
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF009-HTC5
|
3851
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF010-HTC1
|
3311
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF010-HTC2
|
444
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF010-HTC3
|
3385
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF010-HTC4
|
407
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF010-HTC5
|
3001
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF011-HTC1
|
3311
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF011-HTC2
|
444
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF011-HTC3
|
3385
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF011-HTC4
|
407
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF011-HTC5
|
3001
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF012-HTC1
|
3311
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF012-HTC2
|
444
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF012-HTC3
|
3385
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF012-HTC4
|
407
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
KF012-HTC5
|
3001
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
2024-07-09 | ||
|
HTO1-HD-2644-V3D190_spikeB
|
2644
|
Spike+ B | Healthy | 0 | — | ||
|
HTO2-HD-2583-V3D152-PC
|
2583
|
Plasma cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V3D163
|
3536
|
B Naive | Healthy | 0 | — | ||
|
HTO4-SLE-407-V3D178
|
407
|
CD27+ | SLE | 0 | — | ||
|
HTO5-SLE-3001-V3D177
|
3001
|
DN B cells | SLE | 0 | — | ||
|
HTO1-HD-2644-V2D202
|
2644
|
PBMC | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V2D90
|
2583
|
PBMC | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V2D203
|
3536
|
PBMC | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V2D184
|
407
|
PBMC | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V2D138
|
3001
|
PBMC | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V2D110
|
3338
|
PBMC | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-3083-V2D192
|
3083
|
PBMC | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— |